Figures & data
Table 1 Baseline patient characteristics (n=112)
Figure 1 Scatter plot showing relationships between CT-emphysema index/FEV1 COPD phenotypes and GOLD groups among patients (n=112).
Abbreviations: BD, bronchodilator; CT, computed tomography; FEV1, forced expiratory volume in 1 second; GOLD, Global Initiative for Chronic Obstructive Lung Disease.
![Figure 1 Scatter plot showing relationships between CT-emphysema index/FEV1 COPD phenotypes and GOLD groups among patients (n=112).](/cms/asset/c9446a14-7d6d-47f0-8fb6-eec726ea31cf/dcop_a_165898_f0001_c.jpg)
Figure 2 Kaplan–Meier survival probability estimates according to CT-emphysema index/FEV1 COPD phenotypes.
Abbreviations: CT, computed tomography; FEV1, forced expiratory volume in 1 second.
![Figure 2 Kaplan–Meier survival probability estimates according to CT-emphysema index/FEV1 COPD phenotypes.Abbreviations: CT, computed tomography; FEV1, forced expiratory volume in 1 second.](/cms/asset/18eaf0a6-2f7b-4b14-9cb8-72135fcba2cd/dcop_a_165898_f0002_b.jpg)
Figure 3 Kaplan–Meier survival probability estimates according to GOLD 2017 groups. Abbreviation: GOLD, Global Initiative for Chronic Obstructive Lung Disease.
![Figure 3 Kaplan–Meier survival probability estimates according to GOLD 2017 groups. Abbreviation: GOLD, Global Initiative for Chronic Obstructive Lung Disease.](/cms/asset/e2c99e10-8c23-4201-8109-c5deccedfef1/dcop_a_165898_f0003_b.jpg)
Table 2 Predictors in Cox proportional hazard models of COPD-associated mortality